Rallybio Corporation (RLYB)
NASDAQ: RLYB · Real-Time Price · USD
0.2503
-0.0003 (-0.12%)
At close: Apr 11, 2025, 4:00 PM
0.2515
+0.0012 (0.49%)
After-hours: Apr 11, 2025, 7:56 PM EDT
Rallybio Market Cap
Rallybio has a market cap or net worth of $10.42 million as of April 11, 2025. Its market cap has decreased by -82.68% in one year.
Market Cap
10.42M
Enterprise Value
-54.94M
1-Year Change
-82.68%
Ranking
Category
Stock Price
$0.25
Market Cap Chart
Since the IPO on July 29, 2021, Rallybio's market cap has decreased from $405.60M to $10.42M, a decrease of -97.43%. That is a compound annual growth rate of -62.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 11, 2025 | 10.42M | -73.85% |
| Dec 31, 2024 | 39.83M | -55.91% |
| Dec 29, 2023 | 90.33M | -63.67% |
| Dec 30, 2022 | 248.60M | -18.90% |
| Dec 31, 2021 | 306.52M | -24.43% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 657.70B |
| UnitedHealth Group | 548.34B |
| Johnson & Johnson | 365.65B |
| AbbVie | 309.66B |
| Novo Nordisk | 283.15B |
| Abbott Laboratories | 220.05B |
| AstraZeneca | 202.51B |
| Novartis AG | 200.23B |